UnitedHealth reported fourth-quarter results on Thursday that reflected persistent challenges for the health insurance sector ...

In his first public comments since one of his executives was shot to death, UnitedHealth Group CEO Andrew Witty said the ...

Doxycycline postexposure prophylaxis has the potential to substantially reduce real-world population-level incidence of ...

Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price ...

In the last few months, some unscrupulous elements have intensified their illegal operations across the country, freely circulating fake and substandard drugs as well as unwholesome food and drinks.

We recently compiled a list of the 12 Cheapest Stocks with Biggest Upside Potential. In this article, we are going to take a ...

The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing information ...

In a report released on January 9, David Evans from Kepler Capital maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...

The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing informa ...

We recently published a list of the Top 10 Small Cap Stocks to Buy with the Highest Upside Potential. In this article, we are ...